Encana Corporation (NYSE:ECA) belongs to Basic Materials sector. Its net profit margin is 21.30% and weekly performance is -12.27%. On last trading day company shares ended up $9.65. Encana Corporation (NYSE:ECA) distance from 50-day simple moving average (SMA50) is -22.38%. Analysts at Scotiabank lowered their price target on shares of Encana (NYSE:ECA) from $15.00 to $13.00 in a research report issued to clients and investors on Wednesday, MarketBeat reports. Scotiabank’s target price suggests a potential upside of 23.57% from the stock’s previous close.
OncoSec Medical Incorporated (NASDAQ:ONCS) shares fell -1.03% in last trading session and ended the day at $5.75. ONCS return on assets is -53.80%. OncoSec Medical Incorporated (NASDAQ:ONCS) quarterly performance is -12.88%. OncoSec Medical Inc. (NASDAQ:ONCS), announced the appointment of Richard B. Slansky as the Company’s Chief Financial Officer, effective July 6, 2015.
On 10 July, H&R Block, Inc. (NYSE:HRB) shares moved up 2.33% and was closed at $31.18. HRB EPS growth in last 5 year was 5.20%. H&R Block, Inc. (NYSE:HRB) year to date (YTD) performance is -6.22%. On 6 July, it was reported Annual enrollment for H&R Block’s Income Tax Course is open and H&R Block (NYSE:HRB) award full scholarships covering the cost of tuition and books for spouses of active, reserve, wounded warrior and retired military personnel. H&R Block has offered these scholarships for the past 10 years and granted more than $540,000 in scholarship funds to thousands of military spouses in 2014 alone.
Western Asset Mortgage Capital Corporation (NYSE:WMC) ended the last trading day at $14.98. Company weekly volatility is calculated as 1.87% and price to cash ratio as 24.63. Western Asset Mortgage Capital Corporation (NYSE:WMC) showed a weekly performance of -0.20%. Western Asset Mortgage Capital Corporation (NYSE:WMC) announced that its Board of Directors has declared a cash dividend of $0.64 per share for the second quarter of 2015. Today’s dividend is payable on July 28, 2015 to common shareholders of record as of June 29, 2015, with an ex-dividend date of June 25, 2015.
Signal Genetics, Inc. (NASDAQ:SGNL) shares fell -0.50% in last trading session and ended the day at $1.98. SGNL Gross Margin is 17.90% and its return on assets is -89.10%. Signal Genetics, Inc. (NASDAQ:SGNL) quarterly performance is -6.16%. On 30 June, Signal Genetics, Inc. (NASDAQ:SGNL) announced the signing of a Master Service Agreement (MSA) with a leading pharmaceutical company. Under the MSA, Signal’s proprietary MyPRS(R) genetic test will be run across multiple clinical trials in connection with the development of novel treatments for patients with multiple myeloma.